glp-1 agonist common side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists 💊 GLP-1 Weight Loss Medications

Evidence based on recent studies Initially, cases of intestinal obstruction associated with GLP-1 RAs were reported by the European Medicines Agency (EMA) in 2013 [9], and this safety signal is currently being monitored by the United States (US) FDA

Clinical trial data from the STEP 1 and SURMOUNT-1 trials show that patients typically achieve 1015% total body weight loss with semaglutide 2.4 mg weekly (Wegovy) and 1520% with tirzepatide 1015 mg weekly (Zepbound) over 1218 months

Look AHEAD Research Group , EightYear Weight Losses With an Intensive Lifestyle Intervention: The Look AHEAD Study, Obesity 22 (2014): 513

Microdosing of GLP-1's The Rationale for Microdosing While GLP-1 receptor agonists (GLP-1 RAs) are effective treatments, higher doses can cause gastrointestinal side effects such as nausea and vomiting

Please take the discussion that follows as an illustration, not the precise truth

Aim for 0.7-1 gram of protein per pound of ideal body weight daily